Coronavirus Stocks Still on a Tear.
The top ten losers today are down an average of 15% today (with the Dow down 7%), but the top 10 performers...
Adial Pharma (ADIL). Why Quit Drinking When You Can Just Cut Back.
"ONWARD™ showed promising results in reducing heavy drinking in heavy drinking patients, and no overt safety or tolerability concerns."
AYTU (ATYU) ‘Team’ Letter on Innovus (INNV) Acquisition.
Aytu Team:
I’m pleased to share with you some exciting, transformational news about Aytu BioScience that we announced publicly...
Revive’s Quarterly Report, Discussion, and a Video!
With 5,000 hospitalizations reported daily (150,000 a month), contracting Covid is not something to be taken lightly - after you get it....
True Nature|Mitesco President & COO, Julie Smith Interview.
Julie R. Smith is a seasoned senior executive...
Video: Mel Gibson Stem Cell Testimonial.
Fascinating Interview with Joe Rogen, Mel Gibson, and Dr. Neil Riordan, Early Pioneer and Stem Cell Expert.
Joe Rogan...
Hepion Pharma (HEPA): News Archive
UPDATED CONTINUOUSLY..
12/31/2020: News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.
12/23/2020: Remember...
Our Favorite Incubator, Incubates! Telehealth in its Future?
True Nature|Mitesco has found an excellent first Company to incubate and help grow, called MyCare.The founders of the Minute Clinic are teaming...
ABVC BioPharma (ABVC) up 160% on News
And the Day-Traders Say, I'll Drink to That!
LIVE QUOTE
Investment Manager With $1 Billion in Assets Under Management, Buys 300 Hapbee (HAPB) Head...
Things that make you go mmmm.
Randy Eisenman is co-founder and managing partner of Satori Capital with more than...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
